 Men and women over the age of 55 newly diagnosed with lung, breast, colon or rectal cancer, and with an anticipated life expectancy of at least 2 years for breast cancer patients,1 year for patients with lung cancer, and 2 years for patients with colon or rectal cancer. There is no upper age limit for participation in this study. 